-
Enrollment in Phase 2 Study of Parkinson’s Cognitive Treatment Paused
The U.S. safety and tolerability trial will not enroll people with mild cognitive impairment due to Parkinson’s until safety amid COVID-19 is more assured. Click here to read the full story.
Are you part of any research studies that have been delayed or paused due to COVID-19?
Sorry, there were no replies found.
Log in to reply.